Article
Identification of novel drug targets for diamond-blackfan anemia based on RPS19 gene mutation using protein-protein interaction network.
BMC systems biology - 24 Apr 2018
Khan Abbas, Ali Arif, Junaid Muhammad, Liu Chang, Kaushik Aman Chandra, Cho William C S, Wei Dong-Qing
Abstract excerpt
BACKGROUND: Diamond-Blackfan anemia (DBA) is a congenital erythroid aplasia that usually presents in infancy. In order to explore the molecular mechanisms of wild and mutated samples from DBA patients were exposed to bioinformatics investigation. Biological network of differentially expressed genes was constructed. This study aimed to identify novel therapeutic signatures in DBA and uncovered their mechanisms....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
